Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000950103-17-010087
Filing Date
2017-10-19
Accepted
2017-10-19 15:22:30
Documents
1
Effectiveness Date
2017-10-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11816
  Complete submission text file 0000950103-17-010087.txt   12999
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-297095 | Film No.: 171144572
SIC: 2836 Biological Products, (No Diagnostic Substances)